March 9, 2017 / 2:11 PM / 4 months ago

BRIEF-Audentes Therapeutics Q4 loss per share $ 0.91

1 Min Read

March 9 (Reuters) - Audentes Therapeutics Inc:

* Audentes Therapeutics reports fourth quarter and full year 2016 financial results and provides corporate update

* Qtrly loss per share $ 0.91

* Audentes Therapeutics Inc - as of December 31, 2016, Audentes had cash, cash equivalents, and short-term investments of $104.9 million

* Audentes Therapeutics Inc - current cash position is projected to fund operations into late 2018

* Q4 revenue view $0.00 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below